Skip to main content
Top
Published in: Endocrine 3/2007

01-12-2007 | CASE

A case of pheochromocytoma complicated with slowly progressive type 1 diabetes mellitus and chronic thyroiditis

Authors: Koji Murao, Hitomi Imachi, Makoto Sato, Hiroaki Dobashi, Ritsuya Tahara, Reiji Haba, Yoshiyuki Kakehi, Toshihiko Ishida

Published in: Endocrine | Issue 3/2007

Login to get access

Abstract

This is a case report regarding a 45-year-old woman, who has been undergoing treatment for diabetes mellitus (DM) with chronic thyroiditis (euthyroid state). The patient was admitted to our hospital for the evaluation of a right adrenal tumor (50 × 45 mm) and episodic hypertension. She was diagnosed as having pheochromocytoma based on the increased catecholamine and metabolite concentrations and the result of iodine-131 metaiodobenzyl guanidine (131I-MIBG) scintigraphy. Subsequently, the right adrenal tumor was excised. Slowly, progressive type 1 DM (SPIDDM) was confirmed by seropositivity to anti-glutamic acid decarboxylase (1890 U/ml) and the clinical course. After right adrenalectomy, the elevated catecholamine and metabolite concentrations and blood pressure retuned to normal, and the dosage of insulin injection was reduced. However, she still needed the insulin injection therapy to control her blood glucose level. This case exhibited an extremely rare combination of pheochromocytoma and SPIDDM with chronic thyroiditis. Although it is common for patients with pheochromocytoma to exhibit glucose intolerance, this case raises the suggestion that measuring the levels of the autoantibody for pancreatic islet cells should be considered if SPIDDM is suspected in a patient with pheochromocytoma.
Literature
1.
go back to reference K. Pacak, W.M. Linehan, G. Eisenhofer, M.M. Walther, D.S. Goldstein, Ann. Intern. Med. 134, 315–329 (2001)PubMed K. Pacak, W.M. Linehan, G. Eisenhofer, M.M. Walther, D.S. Goldstein, Ann. Intern. Med. 134, 315–329 (2001)PubMed
4.
go back to reference T. Kobayashi, K. Tamemoto, K. Nakanishi, N. Kato, M. Okubo, H. Kajio, T. Sugimoto, T. Murase, K. Kosaka, Diabetes Care. 16, 780–788 (1993)CrossRefPubMed T. Kobayashi, K. Tamemoto, K. Nakanishi, N. Kato, M. Okubo, H. Kajio, T. Sugimoto, T. Murase, K. Kosaka, Diabetes Care. 16, 780–788 (1993)CrossRefPubMed
6.
7.
11.
go back to reference S.A. Metz, J.B. Halter, R.P. Robertson, Diabetes 27, 554–562 (1978)PubMed S.A. Metz, J.B. Halter, R.P. Robertson, Diabetes 27, 554–562 (1978)PubMed
12.
13.
go back to reference T.D. Wiesner, M. Bluher, M. Windgassen, R. Paschke, J. Clin. Endocrinol. Metab. 88, 3632–3636 (2003)CrossRefPubMed T.D. Wiesner, M. Bluher, M. Windgassen, R. Paschke, J. Clin. Endocrinol. Metab. 88, 3632–3636 (2003)CrossRefPubMed
14.
go back to reference H.J. Gjessing, L.E. Matzen, P.C. Pedersen, O.K. Faber, A. Frøland, Diabet. Med. 5, 328–332 (1988)CrossRefPubMed H.J. Gjessing, L.E. Matzen, P.C. Pedersen, O.K. Faber, A. Frøland, Diabet. Med. 5, 328–332 (1988)CrossRefPubMed
15.
go back to reference S. Fourlanos, F. Dotta, C.J. Greenbaum, J.P. Palmer, O. Rolandsson, P.G. Colman, L.C. Harrison, Diabetologia 48, 2206–2212 (2005)CrossRefPubMed S. Fourlanos, F. Dotta, C.J. Greenbaum, J.P. Palmer, O. Rolandsson, P.G. Colman, L.C. Harrison, Diabetologia 48, 2206–2212 (2005)CrossRefPubMed
16.
go back to reference P. Panina-Bordignon, D. Mazzeo, P.D. Lucia, D. D’Ambrosio, R. Lang, L. Fabbri, C. Self, F. Sinigaglia, J. Clin. Invest. 100, 1513–1519 (1997)CrossRefPubMed P. Panina-Bordignon, D. Mazzeo, P.D. Lucia, D. D’Ambrosio, R. Lang, L. Fabbri, C. Self, F. Sinigaglia, J. Clin. Invest. 100, 1513–1519 (1997)CrossRefPubMed
17.
go back to reference V.M. Sanders, R.A. Baker, D.S. Ramer-Quinn, D.J. Kasprowicz, B.A. Fuchs, N.E. Street, J. Immunol. 158, 4200–4210 (1997)PubMed V.M. Sanders, R.A. Baker, D.S. Ramer-Quinn, D.J. Kasprowicz, B.A. Fuchs, N.E. Street, J. Immunol. 158, 4200–4210 (1997)PubMed
19.
go back to reference M. Neufeld, N. Maclaren, R. Blizzard, Pediatr. Ann. 9, 154–162 (1980)PubMed M. Neufeld, N. Maclaren, R. Blizzard, Pediatr. Ann. 9, 154–162 (1980)PubMed
20.
go back to reference J. Meyerson, E.E. Lechuga-Gomez, P.E. Bigazzi, P.G. Walfish, CMAJ 138, 605–612 (1988)PubMed J. Meyerson, E.E. Lechuga-Gomez, P.E. Bigazzi, P.G. Walfish, CMAJ 138, 605–612 (1988)PubMed
21.
go back to reference C. Betterle, R. Zanchetta, Acta Biomed. Ateneo. Parmense. 74, 9–33 (2003) C. Betterle, R. Zanchetta, Acta Biomed. Ateneo. Parmense. 74, 9–33 (2003)
Metadata
Title
A case of pheochromocytoma complicated with slowly progressive type 1 diabetes mellitus and chronic thyroiditis
Authors
Koji Murao
Hitomi Imachi
Makoto Sato
Hiroaki Dobashi
Ritsuya Tahara
Reiji Haba
Yoshiyuki Kakehi
Toshihiko Ishida
Publication date
01-12-2007
Publisher
Springer US
Published in
Endocrine / Issue 3/2007
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-008-9049-y

Other articles of this Issue 3/2007

Endocrine 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine